Form 4: Solenos CCO Sells Shares for Tax Obligations

Solenos Chief Commercial Officer Meredith Manning sold shares to cover tax obligations related to restricted stock unit vesting.

Summary

• Meredith Manning, Chief Commercial Officer of SOLENO THERAPEUTICS INC (SLNO), reported sales of Common Stock.
• The transactions occurred on March 27, 2026, and were made to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• A total of 7,522 shares were sold across three separate transactions.
• The sales were executed at weighted average prices of $30.037, $31.0384, and $31.7187 per share.
• Following these transactions, Meredith Manning beneficially owns 64,507 shares of Common Stock, including certain RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale of shares to cover tax withholding obligations upon RSU vesting is a common and routine practice for executives and does not typically reflect a change in sentiment towards the company's prospects.

Future Outlook

This Form 4 filing reports historical insider transactions and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that Form 4 filings, which report insider transactions, are typically specific to individual executive stock movements and do not inherently provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• Form 4 filings detailing insider stock sales for tax obligations are routine and do not lend themselves to direct comparison with industry-wide financial benchmarks or specific company projects.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, pre-planned transaction for tax purposes and not indicative of a change in the executive's long-term view of the company.

Key Dates

Keywords

SOLENO THERAPEUTICS, SLNO, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Obligations, Meredith Manning